[APLS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
04-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 6.08%
YoY- 24.35%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 22,663 22,056 16,322 14,381 60,290 5,650 623 990.71%
PBT -167,462 -190,823 -155,491 -137,727 -147,581 -195,571 -219,191 -16.38%
Tax -1,471 446 486 1,208 352 2,165 3,706 -
NP -165,991 -191,269 -155,977 -138,935 -147,933 -195,571 -219,191 -16.87%
Tax Rate - - - - - - - -
Total Cost 188,654 213,325 172,299 153,316 208,223 201,221 219,814 -9.66%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -732.43 -867.20 -955.62 -966.10 -245.37 -3,461.43 -35,183.15 -92.37%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -1.50 -1.75 -1.46 -1.42 -1.73 -2.28 -2.72 -32.67%
EPS Diluted -1.50 -1.75 -1.46 -1.42 -1.73 -2.28 -2.72 -32.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.